Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,741 public trials 633 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

DNA Vaccine for Ragweed Allergic Adults

NCT00346086

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Johns Hopkins University School of Medicine Baltimore, Maryland, United States

View Trial Details

Completed

Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

NCT02999711

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations: Regeneron Research Site Belfast, Northern Ireland, United Kingdom

Regeneron Research Site London, United Kingdom

Regeneron Research Site Manchester, United Kingdom

View Trial Details

Completed

Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma

NCT00842270

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis

NCT02595008

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Taro Pharmaceuticals USA Inc. Hawthorne, New York, United States

View Trial Details

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

NCT02932891

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Taro Pharmaceuticals USA Inc. Hawthorne, New York, United States

View Trial Details

Completed

Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

NCT02595073

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Taro Pharmaceuticals USA Inc. Hawthorne, New York, United States

View Trial Details

Completed

A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)

NCT02626221

Conditions: Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
Locations: Novartis Investigative Site CABA, Buenos Aires, Argentina

Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina

Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina

Novartis Investigative Site Lobos, Buenos Aires, Argentina

View all 31 locations

View Trial Details

Completed

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

NCT01522391

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Quintiles Hermelinen AB Luleå, Sweden

View Trial Details

Completed

COMPLliancE and qualiTy of lifE in Asthma

NCT03300076

Conditions: Asthma, Behavior, Bronchial Diseases, +13 more
Locations: Sotiria Pulmonary Hospital Athens, Greece

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

NCT02054130

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Research Site Los Angeles, California, United States

Research Site Los Angeles, California, United States

Research Site Miami, Florida, United States

Research Site Oviedo, Florida, United States

View all 107 locations

View Trial Details